Frontotemporal dementia in genetic forms is highly heterogeneous and begins many years to prior symptom onset, complicating disease understanding and treatment development. Unifying methods to stage the disease during both the presymptomatic and symptomatic phases are needed for the development of clinical trials outcomes. Here we used the contrastive trajectory inference (cTI), an unsupervised machine learning algorithm that analyzes temporal patterns in high-dimensional large-scale population datasets to obtain individual scores of disease stage. We used cross-sectional MRI data (gray matter density, T1/T2 ratio as a proxy for myelin content, resting-state functional amplitude, gray matter fractional anisotropy, and mean diffusivity) from 383 gene carriers (269 presymptomatic and 115 symptomatic) and a control group of 253 noncarriers in the Genetic Frontotemporal Dementia Initiative. We compared the cTI-obtained disease scores to the estimated years to onset (age-mean age of onset in relatives), clinical, and neuropsychological test scores. The cTI based disease scores were correlated with all clinical and neuropsychological tests (measuring behavioral symptoms, attention, memory, language, and executive functions), with the highest contribution coming from mean diffusivity. Mean cTI scores were higher in the presymptomatic carriers than controls, indicating that the method may capture subtle pre-dementia cerebral changes, although this change was not replicated in a subset of subjects with complete data. This study provides a proof of concept that cTI can identify data-driven disease stages in a heterogeneous sample combining different mutations and disease stages of genetic FTD using only MRI metrics.

Data-driven staging of genetic frontotemporal dementia using multi-modal MRI / J. Mccarthy, B. Borroni, R. Sanchez-Valle, F. Moreno, R. Laforce, C. Graff, M. Synofzik, D. Galimberti, J.B. Rowe, M. Masellis, M.C. Tartaglia, E. Finger, R. Vandenberghe, A. de Mendonca, F. Tagliavini, I. Santana, C. Butler, A. Gerhard, A. Danek, J. Levin, M. Otto, G. Frisoni, R. Ghidoni, S. Sorbi, L.C. Jiskoot, H. Seelaar, J.C. van Swieten, J.D. Rohrer, Y. Iturria-Medina, S. Ducharme, S. Afonso, M.R. Almeida, S. Anderl-Straub, C. Andersson, A. Antonell, S. Archetti, A. Arighi, M. Balasa, M. Barandiaran, N. Bargallo, R. Bartha, B. Bender, A. Benussi, L. Benussi, V. Bessi, G. Binetti, S. Black, M. Bocchetta, S. Borrego-Ecija, J. Bras, R. Bruffaerts, M. Canada, V. Cantoni, P. Caroppo, D. Cash, M. Castelo-Branco, R. Convery, T. Cope, M. Cosseddu, M. de Arriba, G. Di Fede, Z. Diaz, A. Diez, D. Duro, C. Fenoglio, C. Ferrari, C. Ferreira, C.B. Ferreira, T. Flanagan, N. Fox, M. Freedman, G. Fumagalli, A. Gabilondo, R. Gasparotti, S. Gauthier, S. Gazzina, G. Giaccone, A. Gorostidi, C. Greaves, R. Guerreiro, C. Heller, T. Hoegen, B. Indakoetxea, V. Jelic, H.-. Karnath, R. Keren, T. Langheinrich, M.J. Leitao, A. Llado, G. Lombardi, S. Loosli, C. Maruta, S. Mead, L. Meeter, G. Miltenberger, R. van Minkelen, S. Mitchell, K.M. Moore, B. Nacmias, M. Neason, J. Nicholas, L. Oijerstedt, J. Olives, S. Ourselin, A. Padovani, J. Panman, J. Papma, G. Peakman, I. Piaceri, M. Pievani, Y. Pijnenburg, C. Polito, E. Premi, S. Prioni, C. Prix, R. Rademakers, V. Redaelli, T. Rittman, E. Rogaeva, P. Rosa-Neto, G. Rossi, M. Rossor, B. Santiago, E. Scarpini, S. Schonecker, E. Semler, R. Shafei, C. Shoesmith, M. Tabuas-Pereira, M. Tainta, R. Taipa, D. Tang-Wai, D.L. Thomas, P. Thompson, H. Thonberg, C. Timberlake, P. Tiraboschi, E. Todd, P. Vandamme, M. Vandenbulcke, M. Veldsman, A. Verdelho, J. Villanua, J. Warren, C. Wilke, I. Woollacott, E. Wlasich, H. Zetterberg, M. Zulaica. - In: HUMAN BRAIN MAPPING. - ISSN 1065-9471. - 43:6(2022), pp. 1821-1835. [10.1002/hbm.25727]

Data-driven staging of genetic frontotemporal dementia using multi-modal MRI

D. Galimberti;E. Scarpini;
2022

Abstract

Frontotemporal dementia in genetic forms is highly heterogeneous and begins many years to prior symptom onset, complicating disease understanding and treatment development. Unifying methods to stage the disease during both the presymptomatic and symptomatic phases are needed for the development of clinical trials outcomes. Here we used the contrastive trajectory inference (cTI), an unsupervised machine learning algorithm that analyzes temporal patterns in high-dimensional large-scale population datasets to obtain individual scores of disease stage. We used cross-sectional MRI data (gray matter density, T1/T2 ratio as a proxy for myelin content, resting-state functional amplitude, gray matter fractional anisotropy, and mean diffusivity) from 383 gene carriers (269 presymptomatic and 115 symptomatic) and a control group of 253 noncarriers in the Genetic Frontotemporal Dementia Initiative. We compared the cTI-obtained disease scores to the estimated years to onset (age-mean age of onset in relatives), clinical, and neuropsychological test scores. The cTI based disease scores were correlated with all clinical and neuropsychological tests (measuring behavioral symptoms, attention, memory, language, and executive functions), with the highest contribution coming from mean diffusivity. Mean cTI scores were higher in the presymptomatic carriers than controls, indicating that the method may capture subtle pre-dementia cerebral changes, although this change was not replicated in a subset of subjects with complete data. This study provides a proof of concept that cTI can identify data-driven disease stages in a heterogeneous sample combining different mutations and disease stages of genetic FTD using only MRI metrics.
disease progression; frontotemporal dementia; magnetic resonance imaging; unsupervised machine learning; Cross-Sectional Studies; Heterozygote; Humans; Language; Magnetic Resonance Imaging; Frontotemporal Dementia
Settore BIO/13 - Biologia Applicata
Article (author)
File in questo prodotto:
File Dimensione Formato  
McCarthy et al.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.25 MB
Formato Adobe PDF
1.25 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/943382
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact